BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4363818)

  • 1. Morphologic changes associated with combined BCNU and radiation therapy in glioblastoma multiforme.
    Willson N; Duffy PE
    Neurology; 1974 May; 24(5):465-71. PubMed ID: 4363818
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy with nitrosourea compounds following surgery plus radiotherapy in glioblastoma multiforme.
    Monfardini S; Brambilla C; Solero CL; Vaghi A; Valagussa P; Morello G; Bonadonna G
    Recent Results Cancer Res; 1978; 68():393-8. PubMed ID: 223206
    [No Abstract]   [Full Text] [Related]  

  • 3. Nothing ventured, nothing gained: Treatment of glioblastoma multiforme in the elderly.
    Shaw EG
    J Clin Oncol; 2004 May; 22(9):1540-1. PubMed ID: 15051758
    [No Abstract]   [Full Text] [Related]  

  • 4. CCNU-chemotherapy of hemispheric supratentorial glioblastoma multiforme.
    Cianfriglia F; Pompili A; Riccio A; Grassi A
    Cancer; 1980 Mar; 45(6):1289-99. PubMed ID: 6244079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled study of CCNU and radiation therapy in malignant astrocytoma.
    Reagan TJ; Bisel HF; Childs DS; Layton DD; Rhoton AL; Taylor WF
    J Neurosurg; 1976 Feb; 44(2):186-90. PubMed ID: 173814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autopsy cases of glioblastoma multiforme: treatment results of high-dose fractionated radiation therapy and CT scan findings].
    Tamura M; Ohye C; Hayakawa K; Niibe H; Ishida Y
    Gan No Rinsho; 1989 Sep; 35(11):1339-46. PubMed ID: 2554007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure.
    Newton HB; Junck L; Bromberg J; Page MA; Greenberg HS
    Neurology; 1990 Nov; 40(11):1743-6. PubMed ID: 2172864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral astrocytomata--trends in radiotherapy and chemotherapy: a review.
    Jones A
    J R Soc Med; 1978 Sep; 71(9):669-74. PubMed ID: 213603
    [No Abstract]   [Full Text] [Related]  

  • 9. Lecture: fotemustine in brain tumors.
    Silvani A; Gaviani P; Lamperti E; Botturi A; Ferrari D; Simonetti G; Salmaggi A
    Neurol Sci; 2011 Nov; 32 Suppl 2():S255-7. PubMed ID: 21987288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches in the treatment of malignant gliomas of the brain.
    Nelson G
    J Neurosurg Nurs; 1974 Dec; 6(2):109-16. PubMed ID: 4140902
    [No Abstract]   [Full Text] [Related]  

  • 11. Fast-neutron irradiation of glioblastoma multiforme. Neuropathological analysis.
    Shaw CM; Sumi SM; Alvord EC; Gerdes AJ; Spence A; Parker RG
    J Neurosurg; 1978 Jul; 49(1):1-12. PubMed ID: 207833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation between clinical and angiographic findings in patients with brain tumors under BCNU chemotherapy.
    Koo AH; Fewer D; Wilson CB; Newton TH
    J Neurosurg; 1972 Jul; 37(1):9-14. PubMed ID: 4338690
    [No Abstract]   [Full Text] [Related]  

  • 13. Sudden onset of blindness in patients treated with oral CCNU and low-dose cranial irradiation.
    Wilson WB; Perez GM; Kleinschmidt-Demasters BK
    Cancer; 1987 Mar; 59(5):901-7. PubMed ID: 3028594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic effect on glioblastoma of chemotherapy on the basis of brain irradiation].
    Qin D; Mo H; Ou G
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):168-9. PubMed ID: 11783028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors.
    Rosenblum ML; Reynolds AF; Smith KA; Rumack BH; Walker MD
    J Neurosurg; 1973 Sep; 39(3):306-14. PubMed ID: 4354763
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of megavolt radiation therapy on glioblastoma multiforme].
    Iashinskas PK; Ragaĭshene VN; Cheponis II
    Vopr Neirokhir; 1976; (1):41-6. PubMed ID: 176816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and molecular characterization of glioblastoma multiforme-derived cancer stem cells.
    Tomuleasa C; Soritau O; Rus-Ciuca D; Ioani H; Susman S; Petrescu M; Timis T; Cernea D; Kacso G; Irimie A; Florian IS
    J BUON; 2010; 15(3):583-91. PubMed ID: 20941832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
    Wald LL; Nelson SJ; Day MR; Noworolski SE; Henry RG; Huhn SL; Chang S; Prados MD; Sneed PK; Larson DA; Wara WM; McDermott M; Dillon WP; Gutin PH; Vigneron DB
    J Neurosurg; 1997 Oct; 87(4):525-34. PubMed ID: 9322843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug.
    Addeo R; De Santi MS; Del Prete S; Caraglia M
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):863-6. PubMed ID: 19639315
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical trial of MCNU for malignant brain tumors].
    Harada K; Okamoto H; Fujioka Y; Uozumi T; Kiya K; Kitaoka T; Goishi A; Sasaki U; Shima T; Inagawa T
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.